Biolife solutions announces the divestiture of its stirling freezer business

Bothell, wash. , april 18, 2024 /prnewswire/ --  biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") and the broader biopharma markets, today announced that it has completed the divestiture of its wholly owned subsidiary global cooling, inc. ("gci" or "stirling").
BLFS Ratings Summary
BLFS Quant Ranking